Skip to main content
SpringerLink
Log in

A bibliometric perspective to the most cited diabetes articles

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Aim

This bibliometric analysis aims to evaluate the characteristics and impact of the top 100 cited articles published under the title of diabetes mellitus.

Metods

We performed to define the most cited articles in diabetes research by using the Web of Science. The papers were analyzed in terms of their year of publication, journal of publication, authors, impact factor (IF), total citations number, the average number of citations per year, studies topic, and type.

Results

The number of citations ranged from 1519 to 17.298. They were published from 1987 to 2018. The most cited articles were published in the New England Journal of Medicine (n = 26), followed by Diabetes Care (n = 17) and Lancet (n = 9). The original scientific paper was the most popular article type (46%), followed by review article (36%). The generality studies’ subject was about treatment (n = 22), followed by pathogenesis (n = 19), etiology and risk factors (n = 16), diagnosis, screening, classification (n = 15), epidemiology (n = 11), prevention (n = 11) and complications (n = 6). There was a correlation between the average number of citations per year (ACpY) and IF (p = < 0.010, r = 0.259), citations and ACpY (p = < 0.001, r = 0.646), citations and time (p = 0.008, r = 0.266).

Conclusion

This study showed that original scientific papers were the most-cited and more articles were published in influential journals. Articles on diabetes treatment and pathogenesis were popular topics. Future interventions should focus on the management and prevention of diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. International Diabetes Federation. (2021) IDF Diabetes atlas. 10th edn. http://www.idf.org/diabetesatlas.

  2. Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol. 2021;17(9):534–48. https://doi.org/10.1038/s41574-021-00512-2.

    Article  PubMed  Google Scholar 

  3. Okaiyeto K, Oguntibeju OO. Trends in diabetes research outputs in South Africa over 30 years from 2010 to 2019: a bibliometric analysis. Saudi J Biol Sci. 2021;28(5):2914–24. https://doi.org/10.1016/j.sjbs.2021.02.025.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–90. https://doi.org/10.1038/s41581-020-0278-5.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Shuaib W, Costa JL. Anatomy of success: 100 most cited articles in diabetes research. Therapeutic Adv Endocrinol Metabolism. 2015;6(4):163–73. https://doi.org/10.1177/2042018815580254.

    Article  CAS  Google Scholar 

  6. Yang Y, Ma Y, Chen L, Liu Y, Zhang Y. The 100 Top-Cited Systematic Reviews/Meta-Analyses on Diabetic Research. J Diabetes Res. 2020;2020:5767582. Published 2020 Sep 11. doi:https://doi.org/10.1155/2020/5767582

  7. Bektan Kanat B, Yavuzer H. Top 100 articles on vitamin D: bibliometric versus altmetric analysis. Bratisl Lek Listy. 2022;123(3):160–71. https://doi.org/10.4149/BLL_2022_027.

    Article  PubMed  Google Scholar 

  8. Diagnostic criteria and classification. Of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103(3):341–63. https://doi.org/10.1016/j.diabres.2013.10.012.

    Article  Google Scholar 

  9. Stout NL, Alfano CM, Belter CW, Nitkin R, Cernich A, Lohmann SK, et al. A bibliometric analysis of the landscape of cancer rehabilitation research (1992–2016. J Natl Cancer Inst. 2018;110(8):815–24. https://doi.org/10.1093/jnci/djy108.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chen X, Chen J, Cheng G, Gong T. Topics and trends in artificial intelligence assisted human brain research. PLoS One. 2020;15(4):e231192.

    Article  Google Scholar 

  11. Coverage analysis of Scopus: a journal metric approach. de Moya-Anegón, Chinchilla-Rodríguez F, Vargas-Quesada Z. B, Corera-Álvarez E, Muñoz-Fernández F, González-Molina A. Scientometrics 2007;73 (1):53–78.

  12. Garfield E. 100 citation classics from the Journal of the American Medical Association. JAMA. 1987;257(1):52–9.

    Article  CAS  PubMed  Google Scholar 

  13. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. https://doi.org/10.1056/NEJM199309303291401.

    Article  Google Scholar 

  14. Shuaib W, Costa JL. Anatomy of success: 100 most cited articles in diabetes research. Ther Adv Endocrinol Metab. 2015;6(4):163–73. https://doi.org/10.1177/2042018815580254.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Rosas S, Schouten J, Cope M, Kagan J. Modeling the dissemination and uptake of clinical trials results. Res Eval. 2013;22:179–86.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Aksnes DW, Langfeldt L. Wouters. Citations, citation indicators, and research quality: an overview of basic concepts and theories. SAGE Open. 2019;9. https://doi.org/10.1177/2158244019829575.

  17. Song Y, Ma P, Gao Y, Xiao P, Xu L, Liu H. A Bibliometrics Analysis of Metformin Development from 1980 to 2019. Front Pharmacol. 2021;12:645810. https://doi.org/10.3389/fphar.2021.645810. Published 2021 Apr 28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Rena G, Hardie DG, Pearson ER. The Mechanisms of Action of Metformin. Diabetologia. 2017;60(9):1577–85. https://doi.org/10.1007/s00125-017-4342-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Forslund K, Hildebrand F, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, et al. Disentangling type 2 diabetes and Metformin Treatment Signatures in the human gut microbiota. Nature. 2015;528(7581):262–6. https://doi.org/10.1038/nature15766.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, et al. Metformin Effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a Randomized, Double-Blind, placebo-controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation1. J Clin Endocrinol Metab. 2000;85(1):139–46. https://doi.org/10.1210/jcem.85.1.6293.

    Article  CAS  PubMed  Google Scholar 

  21. Palmer SC, Tendal B, Mustafa RA et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials [published correction appears in BMJ. 2022 Jan 18;376:o109]. BMJ. 2021;372:m4573. Published 2021 Jan 13. doi:https://doi.org/10.1136/bmj.m4573

  22. Liu H, Guo L, Xing J, et al. The protective role of DPP4 inhibitors in atherosclerosis. Eur J Pharmacol. 2020;875:173037. https://doi.org/10.1016/j.ejphar.2020.173037.

    Article  CAS  PubMed  Google Scholar 

  23. Deacon CF. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16(11):642–53. https://doi.org/10.1038/s41574-020-0399-8.

    Article  CAS  PubMed  Google Scholar 

  24. Naderpoor N, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ. Obesity and polycystic ovary syndrome. Minerva Endocrinol. 2015;40(1):37–51.

    CAS  PubMed  Google Scholar 

  25. Brown AE, Walker M. Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep. 2016;18(8):75. https://doi.org/10.1007/s11886-016-0755-4.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes Mellitus. Endocr Rev. 2016 Jun;37(3):278–316. https://doi.org/10.1210/er.2015-1137. Epub 2016 May 9. PMID: 27159875; PMCID: PMC4890267.

  27. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the study of obesity. Circulation. 2009;120(16):1640–5.

    Article  CAS  PubMed  Google Scholar 

  28. Zou L, Sun L. Global diabetic kidney disease research from 2000 to 2017. Medicine. 2019;98(6):e14394. https://doi.org/10.1097/MD.0000000000014394.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Jaiswal M, Schinske A, Pop-Busui R. Lipids and lipid management in diabetes. Best Pract Res Clin Endocrinol Metab. 2014;28(3):325–38. https://doi.org/10.1016/j.beem.2013.12.001.

    Article  CAS  PubMed  Google Scholar 

  30. Iftikhar PM, Ali F, Faisaluddin M, Khayyat A, De Gouvia De Sa M, Rao T. A bibliometric analysis of the top 30 most-cited Articles in Gestational Diabetes Mellitus Literature (1946–2019). Cureus. 2019;11(2):e4131. https://doi.org/10.7759/cureus.413. Published 2019 Feb 25.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors declare this study to have received no financial support.

Author information

Authors and Affiliations

  1. Division of Geriatric Medicine, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey

    Gulru Ulugerger Avci

Authors
  1. Gulru Ulugerger Avci
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

G UA: concept and design, interpretation of data, analyzed, wrote, reviewed, edited and approved the manuscript.

Corresponding author

Correspondence to Gulru Ulugerger Avci.

Ethics declarations

Conflict of Interest

The authors report no conflict of interest and no competing interests.

Ethical statement

All authors declare that the research has been conducted according to the principles of the World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects.” This study does not require approval from an ethics committee, because it performs a bibliometric analysis/citation analysis of the existing published classical studies.

Informed consent

Informed consent is not required as our work is a retrospective international data study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ulugerger Avci, G. A bibliometric perspective to the most cited diabetes articles. J Diabetes Metab Disord 22, 763–773 (2023). https://doi.org/10.1007/s40200-023-01199-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-023-01199-0

Keywords

Search

Navigation